Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria (PKU)

This study has been withdrawn prior to enrollment.
(poor recruitment)
Sponsor:
Collaborator:
Georgetown University
Information provided by (Responsible Party):
Andrea Gropman, Children's Research Institute
ClinicalTrials.gov Identifier:
NCT01412437
First received: August 1, 2011
Last updated: December 16, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)